重塑药学与治疗学委员会。
Reinventing the pharmacy and therapeutics committee.
作者信息
Shulkin David
出版信息
P T. 2012 Nov;37(11):623-49.
Abstract
As value-based reimbursement and accountable-care models drive us into an era of cost-containment and care-management strategies, the P&T committee must reinvent itself.
摘要
随着基于价值的报销和问责制医疗模式推动我们进入一个成本控制和护理管理策略的时代，药品和治疗委员会必须进行自我重塑。
相似文献
1
Reinventing the pharmacy and therapeutics committee.
P T. 2012 Nov;37(11):623-49.
2
Pharmacy and Therapeutics committee. Cost-containment considerations.
Arch Intern Med. 1992 Sep;152(9):1773-5.
3
Improving pharmacy and therapeutics committee operations.
Am J Hosp Pharm. 1984 Sep;41(9):1767-77.
4
Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
Am J Health Syst Pharm. 2018 Apr 1;75(7):451-455. doi: 10.2146/ajhp170531.
5
Cost containment through P & T committee drug utilization review.
Hosp Formul. 1984 Aug;19(8):699-700, 705-7.
6
P&T Committee antibiotic cost considerations.
Hosp Formul. 1986 Aug;21(8):857-9, 862-4.
7
Editors' roundtable: Current formulas for P & T Committee success (Part 1).
Hosp Formul. 1987 Mar;22(3):288-98.
8
Controlling financial variables--changing prescribing patterns.
Am J Hosp Pharm. 1984 Mar;41(3):503-15.
9
Cost containment efforts of a pharmacy and therapeutics committee.
QRB Qual Rev Bull. 1984 Feb;10(2):38-41.
10
Creating a hospice pharmacy and therapeutics committee.
Am J Hosp Palliat Care. 2002 Mar-Apr;19(2):129-34. doi: 10.1177/104990910201900212.
引用本文的文献
1
Drug and Therapeutics Committee (DTC) evolvement and expanded scope in Ethiopia.
Gates Open Res. 2023 Mar 10;5:70. doi: 10.12688/gatesopenres.13200.2. eCollection 2021.
2
Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures.
Pharm Pract (Granada). 2019 Oct-Dec;17(4):1590. doi: 10.18549/PharmPract.2019.4.1590. Epub 2019 Nov 3.
3
Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.
Am Health Drug Benefits. 2018 Dec;11(9):449-459.
4
The Value of Pediatricians on Pharmacy and Therapeutics Committees.
P T. 2019 Jan;44(1):2-4.
5
The changing roles of p&t committees: a look back at the last decade and a look forward to 2020.
P T. 2014 Nov;39(11):760-72.
本文引用的文献
1
The closed formulary makes a comeback.
Manag Care. 2012 Jul;21(7):21-4.
2
Building an accountable care organization for all the wrong reasons.
Mayo Clin Proc. 2012 Aug;87(8):721-2. doi: 10.1016/j.mayocp.2012.05.012.
3
A Day in the Life: They Provide the Proof When Tough Decisions Have to be Made.
Biotechnol Healthc. 2008 May;5(1):42-51.
4
Quality and financial outcomes from gainsharing for inpatient admissions: a three-year experience.
J Hosp Med. 2010 Nov-Dec;5(9):501-7. doi: 10.1002/jhm.788. Epub 2010 Aug 17.
5
ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.
Am J Health Syst Pharm. 2008 Jul 1;65(13):1272-83. doi: 10.2146/ajhp080086.
6
The evolving use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs.
Med Care. 2005 Jul;43(7 Suppl):20-6. doi: 10.1097/01.mlr.0000170004.17480.49.
7
The effect of changing reimbursement policies on quality of in-patient care, from fee-for-service to prospective payment.
Int J Qual Health Care. 2005 Oct;17(5):421-6. doi: 10.1093/intqhc/mzi055. Epub 2005 Jun 28.
8
Application of pharmacoeconomics to formulary decision making in managed care organizations.
Am J Manag Care. 2002 Feb;8(2):161-9.
9
Increased pressures change P & T Committee makeup.
Manag Care. 2001 Dec;10(12):18-9, 23-4, 27-30.
10
The formulary decision-making process in a US academic medical centre.
Pharmacoeconomics. 1993 Jan;3(1):22-35. doi: 10.2165/00019053-199303010-00004.
Zotero 插件